Costs related to drugs produced by recombinant DNA technology.
Antier
D
D
Vantyghem
C
C
Triaud
F
F
Le Verger
M
M
Grassin
J
J
D002017:Budgets; D003365:Costs and Cost Analysis; D005602:France; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics*
D011994:Recombinant Proteins